Investor Relations
SEC Filing Details

SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
February 07, 2019
Document Date
February 05, 2019
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Proteostasis Therapeutics, Inc.
Issuer
PROTEOSTASIS THERAPEUTICS, INC.
Filer
Dulac Emmanuel

Shareholder Tools